United States · 
Who invested in Syndeio Biosciences?
Syndeio Biosciences's investors include Eli Lilly, Catalio Capital Management and AbbVie.
United States · Venture startup
Who invested in Syndeio Biosciences
Funding summaryUpdated 26 Oct 2026
$90Mraised across 1 round since 2025, from 1 source
- Latest round
- Venture, $90MMay 2025
- Investors
- 3
The rounds
- May 2025
Founders and team
From Syndeio Biosciences's own website: 1 founder, 2 on the team.
Derek SmallCo-founder and Chief Executive Officer
- Michael McCullyPresident and Chief Operating Officer
- Pavel RaifeldChief Executive Officer of Innoviva
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Syndeio Biosciences
How much has Syndeio Biosciences raised?
Syndeio Biosciences has raised $90M across 1 round since 2025.
When did Syndeio Biosciences last raise?
Syndeio Biosciences's most recent round was a Venture of $90M in May 2025.
What was Syndeio Biosciences's biggest round?
Its most recent round, $90M in May 2025, is also its largest on record.
Who backed Syndeio Biosciences first?
Syndeio Biosciences's first round on record, in May 2025, was backed by Eli Lilly, Catalio Capital Management and AbbVie.
What stage is Syndeio Biosciences at?
Syndeio Biosciences's latest named round is a Venture, in May 2025.
Where is Syndeio Biosciences based?
Syndeio Biosciences is based in the United States.
Companies like Syndeio Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.